Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

By M. Stern, K. Williams, C. González‐Villalpando, Kelly J. Hunt, S. Haffner. Diabetes Care, 2004

784 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/95f5c099518dbbd0b6c59b92a78a1fdb6dddb4eb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. J. Despres
2. E. Ford
3. I. Lemieux
4. Simin Liu
5. E. Ferrannini
6. John B. Buse
7. D. Mozaffarian
8. S. Grundy

In Epidemiology

1. J. Despres
2. E. Ford
3. I. Lemieux
4. R. Kahn
5. E. Ferrannini
6. John B. Buse
7. D. Mozaffarian
8. M. Stern

In Molecular Biology

1. E. Ford
2. John B. Buse
3. D. Mozaffarian

Citations in the corpus

• Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association (2009, background): “In a recent analysis of 26 643 US adults, the addition of cystatin C to the combination of creatinine and albuminto-creatinine ratio resulted in a significant improvement in the prediction of both all-cause mortality and the development of ESRD.42 Cardiovascular Disease ● Data from a large national ”
• The metabolic syndrome: time for a critical appraisal (2005, positive): “Additional evidence for the greater predictive value of the Framingham scoring system has been provided by Stern and co-workers [96] in a study of the Hispanic and nonHispanic whites who participated in the San Antonio Heart Study (n=2,570 ), were free of diabetes and CVD at baseline, and were follo”
• Abdominal obesity and metabolic syndrome (2006, background): “largely capture the risk associated with metabolic syndrom”
• Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. (2005, methodology): “Four studies (5,18,26,27) examined the risk of developing diabetes among people with the metabolic syndrome defined by NCEP criteria.”
• Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. (2005, background): “This is likely due to the inclusion of established risk factors for diabetes such as waist circumference (BMI) and high blood glucose levels (short of diabetes), which are not included in the FRS. Exclusion of obesity and high glucose level from the syndrome score reduced the sensitivity of MetS for”